Drugs / tirilazad
tirilazad
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00004759 | Dec 1991 → Aug 2007 | spinal cord injury | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | No outcome recorded |
Evidence & citations 15 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tirilazad | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004759 ↗ |
| Known as | Freedox | ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578 ↗ |
| Known as | PNU 74006F | ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578 ↗ |
| Known as | Tiralazad mesilate hydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578 ↗ |
| Known as | Tiralazad mesylate hydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578 ↗ |
| Known as | Tirilazad mesilate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578 ↗ |
| Known as | Tirilazad mesilate anhydrous | ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578 ↗ |
| Known as | TIRILAZAD MESYLATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578 ↗ |
| Known as | Tirilazad mesylate anhydrous | ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578 ↗ |
| Known as | Tirilazad mesylate hydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578 ↗ |
| Known as | Tirilazad methanesulfonate monohydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578 ↗ |
| Known as | U 74006 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578 ↗ |
| Known as | U-74006F | ChEMBL registry synonym — accepted as the source's own label CHEMBL1630578 ↗ |
| Modality | Small molecule | — CHEMBL1630578 ↗ |
| Route | Intravenous | “Eight additional doses of tirilazad are administered by intravenous push.” NCT00004759 ↗ |